“Autogenous bacterin” vaccines offer an attractive solution to prevent the clinical cases caused by Streptococcus suis in pigs. We evaluated whether a polyvalent vaccine (containing several serotypes of S. suis) has the same efficacy as a monovalent formulation against a given serotype, and if the antibodies induced by these vaccines had cross-reactions between the serotypes.
Presenter: Dominic Dolbec, Faculté de médecine vétérinaire, Université de Montréal, [email protected]
Supervisor : Mariela Segura, [email protected]
Authors, co-authors : Dominic Dolbec1, Sandrine Trudeau1, Annie Gaudreau1, Mélanie Lehoux1, Marcelo Gottschalk1 et Mariela Segura1
1) Research Group on infectious diseases in production animals (GREMIP), Swine and poultry infectious diseases research center (CRIPA), University of Montreal
Some text in the modal.